According to the NIH, people have been using marijuana, also known as cannabis, to help with their health problems for at least 3000 years. But the FDA doesn’t think it’s safe or effective for treating any kind of medical condition. CBD, which is found in cannabis, was approved by the FDA in June 2018 to treat certain types of epilepsy.
For years, extensive research and contentious discussions have revolved around exploring the potential therapeutic qualities of marijuana and its constituents. Certain formulations containing THC have been specifically recognized for their medical advantages. The U.S. Food and Drug Administration (FDA) has granted approval for THC-based medications, namely dronabinol (Marinol®) and nabilone (Cesamet®), which are prescribed in pill form. These medications effectively alleviate nausea in individuals undergoing cancer chemotherapy and stimulate appetite in patients with wasting syndrome caused by AIDS.
Medical marijuana is now been widely accepted and used in many provinces of United States. There are many medical marijuana card service providers online in San Diego. You can find for your local service providers by searching “medical marijuanas card near me”.
Medical Benefits of Medical Marijuana
Can Help With Alcoholism
Another health benefit of cannabis is that it is safer than alcohol. Although it may not be completely risk-free, replacing alcohol with cannabis can be a more effective way to treat alcoholism.
Chronic Pain
In the context of chronic pain, a comprehensive analysis conducted by the National Academies of Sciences, Engineering, and Medicine last year scrutinized over 10,000 scientific studies concerning the potential medical advantages and adverse effects of cannabis. The report paid particular attention to the utilization of medical cannabis for the treatment of chronic pain. Chronic pain, a prevalent condition that incapacitates over 25 million adults in the United States, was the focal point. According to the review, cannabis or products containing cannabinoids, which are the active components of cannabis, as well as other substances that target the same receptors in the brain as cannabis, have been found to be effective in alleviating chronic pain.
Cannabis for Inflammatory Bowel Diseases
Cannabis can be used to treat inflammatory bowel diseases such as Crohn’s disease, Ulcerative Colitis, and others. Cannabidiol and THC are known to boost the immune system while also interacting with cells that are important for gut function. Cannabis helps to block bacteria and other substances that cause intestinal inflammation.
Cannabis for ADHD/ADD
People with Attention Deficit Hyperactivity Disorder (ADHD) and Attention Deficit Disorder (ADD) have difficulty concentrating on tasks. They often struggle with cognitive functioning and focus. Cannabis has been shown to improve attention and concentration in people with ADHD/ADD and is considered safer than Adderall or Ritalin.
Cannabis for Glaucoma
When you have glaucoma, there is pressure on your eyes. This pressure is painful for people with this condition. Cannabis can help relieve the pressure on your eyes and give you temporary relief.
Cancer
Research indicates that oral cannabinoids have demonstrated effectiveness in combating chemotherapy-induced nausea and vomiting, and there are smaller-scale studies suggesting that smoked cannabis may provide relief for these symptoms as well. Certain studies focusing on cancer cells have suggested that cannabinoids may possess the ability to impede growth or even eliminate certain types of cancer. However, initial human studies exploring this hypothesis revealed that while cannabinoids are deemed a safe form of treatment, they do not effectively control or cure cancer.
Improves lung function
When you smoke cigarettes, your lungs are damaged. However, when you smoke cannabis in its natural form, your lungs are not damaged. In fact, one study found that smoking cannabis actually improves lung function rather than damages it.
Epilepsy
In June 2018, the Food and Drug Administration (FDA) granted approval for a medication containing cannabidiol (CBD) to be used in the treatment of two rare and severe types of epilepsy known as Lennox-Gastaut syndrome and Dravet syndrome. These epileptic conditions are challenging to manage with other medications. The CBD-based drug is commonly referred to as Epidiolex.
CBD is one of the many components found in cannabis, and it does not possess psychoactive properties. The treatment for these specific conditions involves a purified form of CBD. The FDA’s approval was based on extensive research and clinical trials conducted.
Recent Studies
A study published in 2017 demonstrated that the administration of CBD resulted in significantly reduced seizure occurrences among children with Dravet syndrome, in comparison to a placebo. Seizures associated with Dravet syndrome are prolonged, repetitive, and potentially life-threatening.
Shockingly, 1 in 5 children with Dravet syndrome do not survive beyond the age of 20. During the study, a group of 120 children and teenagers, aged between 2 and 18, all diagnosed with Dravet syndrome, were randomly assigned to receive an oral CBD solution or a placebo for a period of 14 weeks, in addition to their regular medication.